Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001890017-22-000001
Filing Date
2022-03-29
Accepted
2022-03-29 14:36:46
Documents
1
Effectiveness Date
2022-03-29
Items
Item 06c:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6039
  Complete submission text file 0001890017-22-000001.txt   7179
Mailing Address 1 LIBERTY LANE E SUITE 112 HAMPTON NH 03842
Business Address 1 LIBERTY LANE E SUITE 112 HAMPTON NH 03842 603-339-0084
Novalis LifeSciences Investments II, L.P. (Filer) CIK: 0001890017 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: D/A | Act: 33 | File No.: 021-418587 | Film No.: 22780001